BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 28456517)

  • 1. Proprotein convertase inhibition: Paralyzing the cell's master switches.
    Klein-Szanto AJ; Bassi DE
    Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of proprotein convertases.
    Basak A
    J Mol Med (Berl); 2005 Nov; 83(11):844-55. PubMed ID: 16215768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proprotein convertases: approaches to block squamous carcinoma development and progression.
    de Cicco RL; Bassi DE; Benavides F; Conti CJ; Klein-Szanto AJ
    Mol Carcinog; 2007 Aug; 46(8):654-9. PubMed ID: 17440928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the binding pockets of mammalian proprotein convertases and its implications for the design of specific small molecule inhibitors.
    Tian S; Jianhua W
    Int J Biol Sci; 2010 Feb; 6(1):89-95. PubMed ID: 20151049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cell-based sensor detecting the activity of individual basic proprotein convertases.
    Löw K; Hardes K; Fedeli C; Seidah NG; Constam DB; Pasquato A; Steinmetzer T; Roulin A; Kunz S
    FEBS J; 2019 Nov; 286(22):4597-4620. PubMed ID: 31276291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proprotein convertases: "master switches" in the regulation of tumor growth and progression.
    Bassi DE; Fu J; Lopez de Cicco R; Klein-Szanto AJ
    Mol Carcinog; 2005 Nov; 44(3):151-61. PubMed ID: 16167351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Structure and properties of proprotein convertase inhibitors].
    Kibirev VK; Osadchuk TV
    Ukr Biokhim Zh (1999); 2012; 84(2):5-29. PubMed ID: 22642118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positional Scanning Identifies the Molecular Determinants of a High Affinity Multi-Leucine Inhibitor for Furin and PACE4.
    Małuch I; Levesque C; Kwiatkowska A; Couture F; Ly K; Desjardins R; Neugebauer WA; Prahl A; Day R
    J Med Chem; 2017 Apr; 60(7):2732-2744. PubMed ID: 28287731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proprotein convertases furin and PACE4 play a significant role in tumor progression.
    Bassi DE; Mahloogi H; Klein-Szanto AJ
    Mol Carcinog; 2000 Jun; 28(2):63-9. PubMed ID: 10900462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity.
    Henrich S; Lindberg I; Bode W; Than ME
    J Mol Biol; 2005 Jan; 345(2):211-27. PubMed ID: 15571716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis.
    Bassi DE; Zhang J; Cenna J; Litwin S; Cukierman E; Klein-Szanto AJ
    Neoplasia; 2010 Jul; 12(7):516-26. PubMed ID: 20651981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
    Łepek T; Kwiatkowska A; Couture F; Ly K; Desjardins R; Dory Y; Prahl A; Day R
    Eur J Cell Biol; 2017 Aug; 96(5):476-485. PubMed ID: 28483279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
    Dianati V; Navals P; Couture F; Desjardins R; Dame A; Kwiatkowska A; Day R; Dory YL
    J Med Chem; 2018 Dec; 61(24):11250-11260. PubMed ID: 30501188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Studies Revealed Active Site Distortions of Human Furin by a Small Molecule Inhibitor.
    Dahms SO; Jiao GS; Than ME
    ACS Chem Biol; 2017 May; 12(5):1211-1216. PubMed ID: 28402100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proprotein convertases, 20 years later.
    Seidah NG
    Methods Mol Biol; 2011; 768():23-57. PubMed ID: 21805237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth.
    Bassi DE; Zhang J; Renner C; Klein-Szanto AJ
    Mol Carcinog; 2017 Mar; 56(3):1182-1188. PubMed ID: 27584082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proprotein convertases regulate trafficking and maturation of key proteins within the secretory pathway.
    Cendron L; Rothenberger S; Cassari L; Dettin M; Pasquato A
    Adv Protein Chem Struct Biol; 2023; 133():1-54. PubMed ID: 36707198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules.
    Komiyama T; Coppola JM; Larsen MJ; van Dort ME; Ross BD; Day R; Rehemtulla A; Fuller RS
    J Biol Chem; 2009 Jun; 284(23):15729-38. PubMed ID: 19332539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Insights into Structure-Activity Relationships of N-Terminally Modified PACE4 Inhibitors.
    Kwiatkowska A; Couture F; Levesque C; Ly K; Beauchemin S; Desjardins R; Neugebauer W; Dory YL; Day R
    ChemMedChem; 2016 Feb; 11(3):289-301. PubMed ID: 26751825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.